Megan Dempsey

Megan Dempsey is a Process Development Scientist at Prothelia. Prior to Prothelia, Megan worked in upstream process development at MassBiologics scaling up production of antibodies and other therapeutic biomolecules. Beyond biotech, Megan’s experience has spanned from medical device design to human mesenchymal stem cell enrichment. Megan received a BS in Biomedical Engineering from Worcester Polytechnic Institute and a PhD in Biomedical Engineering from Brown University.